Consolidated figures · ₹ crore
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 2,306 | 2,590 | 2,839 | 3,511 | |
| 1,910 | 2,084 | 2,305 | 2,892 | |
| 396 | 505 | 534 | 619 | |
| OPM % | 17.2% | 19.5% | 18.8% | 17.6% |
| Depreciation | 60 | 76 | 80 | 126 |
| Interest | 31 | 49 | 22 | 19 |
| 60 | 79 | 107 | 52 | |
| Profit before tax | 363 | 459 | 539 | 525 |
| Tax | 97 | 122 | 133 | 124 |
| Tax % | 26.7% | 26.6% | 24.6% | 23.6% |
| 266 | 337 | 407 | 401 | |
| PAT margin % | 11.5% | 13% | 14.3% | 11.4% |
| EPS (₹) | — | 15.2 | 17.2 | 16.7 |
| EPS adjusted (₹) | 12 | 15.5 | 17 | 16.7 |
| — | 0% | 11.7% | 13.5% | |
| Annual report | — | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 44 | 44 | 48 | 48 |
| Reserves | 1,020 | 1,385 | 2,568 | 3,091 |
| 464 | 403 | 0 | 0 | |
| 676 | 713 | 710 | 1,482 | |
| Total equity & liabilities | 2,204 | 2,546 | 3,326 | 4,620 |
| 559 | 646 | 678 | 1,812 | |
| CWIP | — | — | 4 | 12 |
| Investments | 614 | 797 | 1,290 | 1,100 |
| 1,031 | 1,103 | 1,355 | 1,697 | |
| Total assets | 2,204 | 2,546 | 3,326 | 4,620 |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 130 | 508 | 442 | 651 | |
| -893 | -327 | -683 | -512 | |
| 333 | -66 | 288 | -83 | |
| Net cash flow | -430 | 114 | 47 | 56 |
| Free cash flow | 111 | 497 | 412 | 607 |
| CFO / Operating profit % | 32.9% | 100.5% | 82.7% | 105.1% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Enterprise Commercial Solutions | 2,460.5 | 449.2 | 0 | 0 |
| Enterprise Medical Solutions | 929.8 | 243.5 | 0 | 0 |
| Others | 120.2 |
| -32.7 |
| 0 |
| 0 |
₹ crore by fiscal year